EUVIMEDEUVIMED entdecken
Crossref

EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis

Rui Wang, Chi Lv, Donghao Li, Yutong Song, Zhaopeng Yan iD

International Journal of Cancer · 2024

DOI: 10.1002/ijc.35039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Rui Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China. Hauptthemen laut MEDLINE: Cell Proliferation, Colorectal Neoplasms, Gene Expression Regulation, Neoplastic, Peptide Elongation Factor 1. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Foundation of Liaoning Province, Shengjing Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is the third most common cancer and causes high mortality worldwide. Although CRC has been studied widely, the molecular mechanism is not completely known. Eukaryotic translation elongation factor 1 delta (EEF1D) participates in the progression of various tumors, however, the effect of EEF1D on CRC remains unclear. Here, we aimed to identify the potential mechanism of EEF1D in CRC. The expression levels of EEF1D were assessed in CRC samples. Functional analysis of EEF1D in CRC was detected in vitro and in vivo. The regulatory mechanism of EEF1D was identified with RNA immunoprecipitation, RNA pull‐down assay, and proteomics analysis. Our findings confirmed that EEF1D was upregulated in human CRC tissues. Functionally, EEF1D overexpression accelerated cell proliferation and metastasis, whereas EEF1D knockdown inhibited cell proliferation and metastasis both in vitro and in vivo CRC models. Furthermore, we showed that EEF1D was upregulated by SRSF9 via binding to 3′UTR of EEF1D mRNA. EEF1D knockdown reversed the malignant phenotype induced by SRSF9 overexpression. These findings demonstrated that EEF1D promotes CRC progression, and EEF1D may be a molecular target against CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationColorectal NeoplasmsGene Expression Regulation, NeoplasticPeptide Elongation Factor 1Serine-Arginine Splicing FactorsAnimalsFemaleHumansMaleMice3' Untranslated RegionsCell Line, TumorCell MovementMice, NudeNeoplasm MetastasisUp-Regulation

Stichwörter der Autor:innen

EEF1DSRSF9colorectal cancermetastasisproliferation

Substanzen

3' Untranslated RegionsEEF1D protein, humanPeptide Elongation Factor 1Serine-Arginine Splicing FactorsSRSF9 protein, human

Autor:innen und Institutionen

  • Department of Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang, China.
  • Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China.

ORCID-Profile: Zhaopeng Yan

Förderung

  • Natural Science Foundation of Liaoning Province
  • Shengjing Hospital

Zitieren

APA

Wang, R., Lv, C., Li, D., Song, Y., & Yan, Z. (2024). EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis. International Journal of Cancer. https://doi.org/10.1002/ijc.35039

Vancouver

Wang R, Lv C, Li D, Song Y, Yan Z. EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis. International Journal of Cancer. 2024. doi:10.1002/ijc.35039

BibTeX
@article{Wang2024,
  author = {Wang, Rui and Lv, Chi and Li, Donghao and Song, Yutong and Yan, Zhaopeng},
  title = {EEF1D stabilized by SRSF9 promotes colorectal cancer via enhancing the proliferation and metastasis},
  journal = {International Journal of Cancer},
  year = {2024},
  doi = {10.1002/ijc.35039}
}
Kostenlos starten →